Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
EMvision Medical Devices Ltd. ( (AU:EMV) ) just unveiled an update.
EMVision Medical Devices Ltd has successfully executed a Cooperative Research Centres Projects (CRC-P) Grant Agreement with the Australian Government, receiving an initial payment of $453,566. This grant will support a collaborative project aimed at improving stroke diagnosis and management in regional emergency departments across Australia, utilizing EMVision’s emu™ point-of-care brain scanner. The study aims to demonstrate the clinical benefits of this technology, potentially leading to widespread adoption and improved patient outcomes in underserved rural areas.
The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Limited is an innovative Australian medical device company focused on developing portable, non-invasive, affordable, and safe neurodiagnostic devices. The company’s vision is to enhance the timely diagnosis and treatment of stroke and other time-sensitive medical emergencies at the point-of-care.
Average Trading Volume: 68,577
Technical Sentiment Signal: Sell
Current Market Cap: A$168.7M
For detailed information about EMV stock, go to TipRanks’ Stock Analysis page.